Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Imaging: Non-radioactive/Multimodal Imaging: Non-radioactive Probe Development

Tubulin derived peptides as optical imaging probes targeting RHAMM

Kenneth Virgel Esguerra, Jing Zhang, Choi-Fong Cho, John Lewis, Eva Turley and Leonard Luyt
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 394;
Kenneth Virgel Esguerra
1Chemistry, University Western Ontario, London, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jing Zhang
3Oncology, London Regional Cancer Program, London, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Choi-Fong Cho
2Medical Biophysics, University Western Ontario, London, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Lewis
3Oncology, London Regional Cancer Program, London, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eva Turley
3Oncology, London Regional Cancer Program, London, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leonard Luyt
1Chemistry, University Western Ontario, London, ON, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

394

Objectives The receptor for hyaluronan-mediated motility (RHAMM) is a hyaluronan (HA) binding protein expressed in breast cancer lines that exhibit progenitor capability and thus development of an imaging probe for this biomarker could aid in breast cancer imaging. The carboxy terminal tail (CTT) region of tubulins has been shown to interact with kinesins, which have structural homology to RHAMM. We hypothesize that peptide fragments derived from tubulin CTTs may have affinity for RHAMM and may be useful compounds for developing a molecular imaging probe.

Methods 12-mer peptides corresponding to the CTT of different tubulin subtypes were synthesized, biotinylated and their affinities for RHAMM-CT were assessed using ELISA. Candidate peptides were conjugated to FITC and their specificities for MDA-MB-231 cells were evaluated using a cellular fluorescence assay. Peptides were also conjugated with cysteine for immobilization to a gold-plated sensor and their binding affinities determined using surface plasmon resonance (SPR) spectroscopy.

Results Tubulin CTTs corresponding to the α- and β-subtypes showed affinity for RHAMM as indicated by ELISA studies, with α-CTT having the highest affinity. The breast cancer cell line MDA-MB-231 showed intra-cellular fluorescence when incubated with the dye-conjugated peptides. Cells blocked with anti-RHAMM showed 25-45% reduction in cellular fluorescence with the α-CTT variant demonstrating the highest specificity. Using SPR, the binding affinities (KD) of the cysteine-conjugated peptides were evaluated, with α-CTT having a KD of 24±2 nM and β-CTT a KD of 32±3 nM. In addition, peptide sequences directly adjacent to CTTs with reported affinity for kinesins were evaluated.

Conclusions These experiments indicate that α- and β-CTT were able to specifically target RHAMM expressing tumour cells. Further assessment of these optical-based probes may facilitate translation into isotope-based imaging probes.

Research Support OIC

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 51, Issue supplement 2
May 2010
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Tubulin derived peptides as optical imaging probes targeting RHAMM
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Tubulin derived peptides as optical imaging probes targeting RHAMM
Kenneth Virgel Esguerra, Jing Zhang, Choi-Fong Cho, John Lewis, Eva Turley, Leonard Luyt
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 394;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Tubulin derived peptides as optical imaging probes targeting RHAMM
Kenneth Virgel Esguerra, Jing Zhang, Choi-Fong Cho, John Lewis, Eva Turley, Leonard Luyt
Journal of Nuclear Medicine May 2010, 51 (supplement 2) 394;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Molecular Imaging: Non-radioactive/Multimodal Imaging: Non-radioactive Probe Development

  • Multimodality molecular imaging with activatable fluorescence and radioscintigraphy for specific and quantitative targeted cancer detection
  • Biomedical effect of 125I-AFPasON in HCC evaluated with Raman spectra
  • Multimodality radionuclide and fluorescent tumor imaging in mice using a streptavidin nanoparticle
Show more Molecular Imaging: Non-radioactive/Multimodal Imaging: Non-radioactive Probe Development

Molecular Imaging: Non-radioactive Probe Development I

  • Reduction of kidney uptake in near-infrared fluorescent imaging of integrin α2β1 expression using the peptide linker strategy
  • Stem cell tracking with membrane intercalating near infrared (NIR) fluorescent dyes
  • Functionalization of polyamidoamine dendrimers for multi-modality molecular imaging and in vivo cell tracking
Show more Molecular Imaging: Non-radioactive Probe Development I

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire